| abstract |
Provided herein is new and selective high affinity α 3 β 4 nicotinic acetylcholine-receptor ligands and Pharmaceutical composition thereof.In other embodiments, it provided herein that use compound disclosed herein and composition treatment, prevent or improve multiple illness, such as, drug addiction or the method for pain.In other other embodiments, it provided herein that the method for modulation nAChR (nAChR).In other other embodiments, it provided herein that use compound disclosed herein and composition optionally antagonism acceptor, such as, the method for α 3 β 4 nAChR. |